Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Implantable Duodenal Liner Improves Insulin Resistance

By HospiMedica International staff writers
Posted on 24 Oct 2019
A new device that combines an intragastric balloon with a connecting sleeve mimics the effects of traditional bariatric surgery on people with obesity and Type 2 diabetes (T2D).

Developed at Sapienza University (Rome, Italy), Università Cattolica del S. More...
Cuore (UCSC; Rome, Italy), King’s College London (KCL; United Kingdom), and other institutions, the Sleeveballoon device consists of an intra-gastric balloon with a central channel to allow passage of food into the proximal small bowel, which is then covered by a sleeve that extends into the duodenum and proximal jejunum. This reduces gastric volume by 2/3, while the sleeve bypasses the proximal small bowel, delivering food directly to the mid-jejunum. The device is intended for use for a period of 12-18 months.

In study to compare the effect of the Sleeveballoon and Roux-en-Y Gastric-Bypass (RYGB) in a rat model, the animals were fed a high-fat diet (HFD), with fasting insulin sensitivity, insulin signaling, and gastric emptying compared. The results revealed that both hepatic and whole-body insulin sensitivity improved, body weight and ectopic fat deposition were reduced, glycogen content in both liver and skeletal muscle was increased, and gastric emptying and cardiac function were improved in both Sleeveballoon and RYGB, versus sham-operated rats. The study was published in the August 2019 issue of EBioMedicine.

“We found that the metabolic effects of the Sleeveballoon device are similar to those of the gastric bypass, but have distinct advantages over the traditional method. In both, insulin sensitivity and heart functions improved,” said senior author Professor Geltrude Mingrone, of UCSC and KCL. “However, while gastric bypass causes a rapid rise in post food blood glucose levels which can cause hypoglycemia, the Sleeveballoon induces a slowing down of digestion, which has a steadying effect on blood sugar levels. This helps control appetite and hunger, keeping the person fuller for longer, and substantially reduces weight.”

The RYGB procedure has been the gold standard for surgical weight loss intervention for many years. The procedure usually involves laparoscopic minimally invasive surgery to create a stomach pouch from the larger stomach body. A portion of the small intestine is then connected to the stomach pouch, leaving a small opening for food to travel. The result is a sensation of satiety or fullness after eating small meals.

Related Links:
Sapienza University
Università Cattolica del S. Cuore
King’s College London


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.